ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 24 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $8,105,547 | +228.4% | 204,479 | +57.9% | 0.00% | +300.0% |
| Q4 2023 | $2,467,870 | +1130.9% | 129,479 | +639.4% | 0.00% | – |
| Q3 2023 | $200,501 | -84.7% | 17,511 | -86.2% | 0.00% | -100.0% |
| Q2 2023 | $1,308,901 | +1049.4% | 127,325 | +763.2% | 0.00% | – |
| Q1 2023 | $113,877 | +90.0% | 14,751 | +80.9% | 0.00% | – |
| Q4 2022 | $59,939 | +3.3% | 8,155 | +1.3% | 0.00% | – |
| Q3 2022 | $58,000 | -24.7% | 8,049 | -11.4% | 0.00% | – |
| Q2 2022 | $77,000 | +35.1% | 9,089 | +44.3% | 0.00% | – |
| Q1 2022 | $57,000 | -41.8% | 6,300 | -10.5% | 0.00% | – |
| Q4 2021 | $98,000 | +38.0% | 7,042 | +5.4% | 0.00% | – |
| Q3 2021 | $71,000 | -94.1% | 6,680 | -95.0% | 0.00% | -100.0% |
| Q2 2021 | $1,207,000 | -53.4% | 134,057 | -45.1% | 0.00% | 0.0% |
| Q1 2021 | $2,590,000 | +64650.0% | 244,332 | +22842.0% | 0.00% | – |
| Q4 2019 | $4,000 | +300.0% | 1,065 | +163.0% | 0.00% | – |
| Q4 2018 | $1,000 | -99.8% | 405 | -99.4% | 0.00% | – |
| Q3 2018 | $433,000 | -29.6% | 68,528 | -15.7% | 0.00% | – |
| Q2 2018 | $615,000 | +104.3% | 81,338 | +115.9% | 0.00% | – |
| Q1 2018 | $301,000 | +56.0% | 37,680 | +117.9% | 0.00% | – |
| Q4 2017 | $193,000 | -24.9% | 17,292 | -22.2% | 0.00% | – |
| Q3 2017 | $257,000 | – | 22,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|